Please login to the form below
Novo Nordisk and Valo Health agree deal worth up to $3.3bn to develop cardiovascular treatments
The companies will work together to develop new cardiovascular treatments
Merck announces partnerships worth $1.3bn with BenevolentAI and Exscientia
The deals aim to accelerate drug development in oncology, neurology and immunology
Eli Lilly files US lawsuits over ‘unlawful’ sales of Mounjaro counterfeits
Lilly is the only FDA-approved company to legally sell products containing tirzepatide
Date set for EU antitrust regulators to decide on Pfizer’s $43bn Seagen acquisition
The proposed transaction would mark a significant boost to the US pharma’s oncology pipeline
Moderna and Immatics announce oncology collaboration worth over $1.7bn
The agreement will focus on the development of bispecifics, cell therapies and cancer vaccines
AstraZeneca’s rare disease unit partners with Verge Genomics in deal worth over $840m
Both will identify drug targets for neurodegenerative and neuromuscular diseases
BMS pays Zenas $50m upfront for regional rights to autoimmune disease antibody
The company will gain exclusive rights to develop and commercialise obexelimab
Novo Nordisk acquires Embark Biotech in deal worth over €470m
Novo gains access to Embark's lead asset targeting obesity and other cardiometabolic diseases
LEO Pharma to acquire Timber Pharmaceuticals in deal worth up to $36m
The transaction gives LEO access to Timber’s lead investigational candidate, TMB-001
Health coverage across state lines
Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad
-
Standing out in a crowdCelltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars
-
The diseased organisationLike humans, organisations can be afflicted by genetic disorders that hinder performance and threaten survival but these can be understood and cured
-
Novo Nordisk to acquire metabolic disorders specialist Inversago Pharma for $1bnThe deal includes a CB1 blocker being developed to treat metabolic syndrome and its associated complications
-
Regeneron to acquire Decibel Therapeutics in deal worth up to $213mThe transaction expands the company’s gene therapy and hearing loss pipeline
-
BioNTech and Duality Biologics add third ADC candidate to oncology partnershipThe companies announced the original agreement covering two antibody-drug conjugates in April
-
Astellas invests $50m to support advancement of Poseida’s cancer cell therapyThe company will gain the first refusal to one of Poseida’s clinical stage programmes
-
Merck and Ginkgo Bioworks enter biologic manufacturing collaboration worth up to $490mThe companies partnered last year to improve Merck's active pharmaceutical ingredient manufacturing
-
MSD and Astex announce expansion to oncology drug discovery collaborationAstex will receive $35m upfront plus milestone payments totalling $500m per programme
-
TG signs $645m deal with Neuraxpharm to support international launch of MS antibodyBriumvi has already been approved in the US and EU for adults with relapsing forms of MS
-
New hires at Ferring, Flexion and Immunocore The latest movers in pharma
-
New hires at Nanoform, Leo Pharma and CalliditasThe latest movers in pharma and biotech
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMOLatest movers in pharma and biotech
-
New hires at Mundipharma, Sinclair Pharma and Relay TherapeuticsLatest movers in pharma
-
Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership teamThe latest industry movers
Latest sales appointments
Subscribe to our email news alerts
- Contagious Conversations: Exploring Infectious Disease in the Digital Age
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
No results were found
PMHub
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
